Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Aspen, FirstRand, Petmin, Zeder: South African Equity Preview

Sept. 13 (Bloomberg) -- The following stocks may rise or fall in South Africa. Symbols are in parentheses and prices are from the last close.

The FTSE/JSE Africa All Share Index declined the most in a week, falling 585.12, or 1.9 percent, to 29,855.75 by the 5 p.m. close in Johannesburg.

Aspen Pharmacare Holdings Ltd. (APN SJ): The largest maker of generic medicines in the southern hemisphere announces results for the 12 months through June. Earnings per share increased by as much as 22 percent, the company said in a trading update on Sept. 2. Shares in the company dropped 0.8 percent to 87.01 rand.

FirstRand Ltd. (FSR SJ): South Africa’s second-largest banking group releases results for the year to June 30. Basic earnings per share will increase by between 110 percent and 115 percent from a year earlier after the company unbundled life insurance subsidiary Momentum Group Ltd. and property and casualty insurer OUTsurance Holdings Ltd., it said in a trading statement on Sept. 8. FirstRand fell 2.2 percent to 20.05 rand.

Petmin Ltd. (PET SJ): South Africa’s largest anthracite coal miner releases results for the year to June 30. Shares in the company closed 2.9 percent lower at 2.72 rand.

Zeder Investments Ltd. (ZED SJ): The agricultural investment group received acceptances from Capespan Group Ltd. shareholders of 2.9 million shares, or about 1 percent of the company’s stock, for its offer of 2.25 rand a share. In a separate regulatory filing, the group said it bought another 11.5 percent of Capespan shares in the market. The stock closed unchanged at 2.35 rand.

To contact the reporter on this story: Stephen Gunnion in Johannesburg at sgunnion@bloomberg.net

To contact the editor responsible for this story: Gavin Serkin at gserkin@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.